The bottom lineTuesday, June 18th, 2013
I’ll conclude this little article review with an anecdote. I recently had dinner with a friend who was telling me about the relative difficulties of raising capital for funding something like an HIV drug trial versus a “small tech startup”. The bottom line was: why spend $200 million on a potentially lifesaving drug when you could fund a couple of hundred startups in hopes of 1 or 2 becoming billion dollar companies? This anecdote left me uncomfortably unable to find a silver lining: how do we as a society make sure that all capital doesn’t end up funding text boxes and photo-sharing instead of other critical innovation?
This entry was posted on Tuesday, June 18th, 2013 at 7:00 am and is filed under business, Internet. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.